Published in J Thromb Haemost on December 01, 2010
The immunological synapse: a molecular machine controlling T cell activation. Science (1999) 17.41
Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science (1997) 8.43
Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell (1996) 7.81
Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science (1999) 5.22
The immunological synapse. Annu Rev Immunol (2001) 4.45
A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell contacts. Cell (1998) 4.21
Partial T cell signaling: altered phospho-zeta and lack of zap70 recruitment in APL-induced T cell anergy. Cell (1994) 3.71
Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures. Gut (2008) 3.57
Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J Clin Invest (2001) 3.22
Signal transduction: hanging on a scaffold. Curr Opin Cell Biol (2000) 2.96
Signal transduction through decay-accelerating factor. Interaction of glycosyl-phosphatidylinositol anchor and protein tyrosine kinases p56lck and p59fyn 1. J Immunol (1992) 2.79
Palmitylation of an amino-terminal cysteine motif of protein tyrosine kinases p56lck and p59fyn mediates interaction with glycosyl-phosphatidylinositol-anchored proteins. Mol Cell Biol (1993) 2.29
The immunological synapse and CD28-CD80 interactions. Nat Immunol (2001) 2.23
Fidelity of T cell activation through multistep T cell receptor zeta phosphorylation. Science (1998) 2.13
14-3-3 proteins are required for maintenance of Raf-1 phosphorylation and kinase activity. Mol Cell Biol (1998) 2.07
Cytoskeletal polarization and redistribution of cell-surface molecules during T cell antigen recognition. Semin Immunol (2000) 2.06
CD2AP localizes to the slit diaphragm and binds to nephrin via a novel C-terminal domain. Am J Pathol (2001) 1.97
Thrombin generation and myocardial infarction during infusion of tissue-plasminogen activator. Lancet (1993) 1.96
p59fyn tyrosine kinase associates with multiple T-cell receptor subunits through its unique amino-terminal domain. Mol Cell Biol (1992) 1.87
Primary testicular lymphoma. Clin Oncol (R Coll Radiol) (2012) 1.70
Streptokinase resistance: when might streptokinase administration be ineffective? Br Heart J (1992) 1.66
P62 association with RNA is regulated by tyrosine phosphorylation. J Biol Chem (1995) 1.59
Guidelines on use of vena cava filters. Br J Haematol (2006) 1.58
Association of p62, a multifunctional SH2- and SH3-domain-binding protein, with src family tyrosine kinases, Grb2, and phospholipase C gamma-1. Mol Cell Biol (1995) 1.58
Proof of principle of potential clinical utility of multiple SNP analysis for prediction of recurrent venous thrombosis. J Thromb Haemost (2008) 1.53
The 14-3-3 proteins positively regulate rapamycin-sensitive signaling. Curr Biol (1998) 1.53
The conserved box 1 motif of cytokine receptors is required for association with JAK kinases. J Biol Chem (1995) 1.51
Accuracy of hepatocellular carcinoma detection on multidetector CT in a transplant liver population with explant liver correlation. Clin Radiol (2011) 1.50
Distinct p53/56lyn and p59fyn domains associate with nonphosphorylated and phosphorylated Ig-alpha. Proc Natl Acad Sci U S A (1994) 1.49
Costimulation: building an immunological synapse. Science (1999) 1.48
CD2AP is expressed with nephrin in developing podocytes and is found widely in mature kidney and elsewhere. Am J Physiol Renal Physiol (2000) 1.48
A randomized trial of solvent/detergent-treated and standard fresh-frozen plasma in the coagulopathy of liver disease and liver transplantation. Transfusion (2000) 1.48
Cutting edge: distinct motifs within CD28 regulate T cell proliferation and induction of Bcl-XL. J Immunol (2001) 1.47
Interactions of p59fyn and ZAP-70 with T-cell receptor activation motifs: defining the nature of a signalling motif. Mol Cell Biol (1994) 1.45
Proline residues in CD28 and the Src homology (SH)3 domain of Lck are required for T cell costimulation. J Exp Med (1999) 1.44
Predicting response to recombinant factor VIIa in non-haemophiliac patients with severe haemorrhage. Br J Anaesth (2006) 1.39
Is platelet phospholipid-dependent thrombin generation altered by acute myocardial infarction or aspirin? Thromb Res (1996) 1.38
Regulation of antigen receptor signal transduction by protein tyrosine kinases. Curr Opin Immunol (1996) 1.38
Platelet size has diagnostic predictive value in patients with thrombocytopenia. Clin Lab Haematol (2005) 1.36
Ligand-induced assembly and activation of the gamma interferon receptor in intact cells. Mol Cell Biol (1996) 1.32
Reconstitution of Syk function by the ZAP-70 protein tyrosine kinase. Immunity (1995) 1.28
Binding of ZAP-70 to phosphorylated T-cell receptor zeta and eta enhances its autophosphorylation and generates specific binding sites for SH2 domain-containing proteins. Mol Cell Biol (1995) 1.27
Analysis of the interaction of ZAP-70 and syk protein-tyrosine kinases with the T-cell antigen receptor by plasmon resonance. Proc Natl Acad Sci U S A (1995) 1.26
Structure-function analysis of SH3 domains: SH3 binding specificity altered by single amino acid substitutions. Mol Cell Biol (1995) 1.26
Comparison of p56lck and p59fyn protein expression in thymocyte subsets, peripheral T cells, NK cells, and lymphoid cell lines. J Immunol (1995) 1.20
Identification and removal of a promiscuous CD4+ T cell epitope from the C1 domain of factor VIII. J Thromb Haemost (2005) 1.07
CD28 and the tyrosine kinase lck stimulate mitogen-activated protein kinase activity in T cells via inhibition of the small G protein Rap1. Mol Cell Biol (2000) 1.06
Re: Multicentre survey of radiologically inserted gastrostomy feeding tube (RIG) in the UK. Clin Radiol (2012) 1.06
Imaging patients with myeloma. Clin Radiol (2008) 1.06
Identification of an interferon-gamma receptor alpha chain sequence required for JAK-1 binding. J Biol Chem (1996) 1.05
The diagnosis and management of factor VIII and IX inhibitors: a guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO). Br J Haematol (2000) 1.04
Environmental control of immunological synapse formation and duration. Trends Immunol (2001) 1.01
Coordinate regulation of T cell activation by CD2 and CD28. J Immunol (2000) 1.00
HIV-1 Nef protein downregulation of CD4 surface expression: relevance of the lck binding domain of CD4. Virology (1995) 0.99
Susceptibility to acyclovir of herpes simplex virus: emergence of resistance in patients with lymphoid and myeloid neoplasia. J Infect (1989) 0.97
Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrence. Br J Haematol (2007) 0.95
An assessment of the efficacy of antimicrobial prophylaxis in bone marrow autografts. Bone Marrow Transplant (1991) 0.95
Multiple features of the p59fyn src homology 4 domain define a motif for immune-receptor tyrosine-based activation motif (ITAM) binding and for plasma membrane localization. J Cell Biol (1996) 0.94
Quantitation of reticulated platelets: methodology and clinical application. Br J Haematol (1995) 0.93
Aberrant expression of CD19 in AML with t(8;21) involves a poised chromatin structure and PAX5. Oncogene (2010) 0.92
The first reported outbreak of dengue hemorrhagic fever in Irian Jaya, Indonesia. Am J Trop Med Hyg (1997) 0.90
Platelet aggregation in response to four low molecular weight heparins and the heparinoid ORG 10172 in patients with heparin-induced thrombocytopenia. Br J Haematol (1994) 0.90
Thrombin generation by apoptotic vascular smooth muscle cells. Blood (1997) 0.89
Temozolomide responsiveness in aggressive corticotroph tumours: a case report and review of the literature. Pituitary (2012) 0.87
Virtual unenhanced second generation dual-source CT of the liver: is it time to discard the conventional unenhanced phase? Eur J Radiol (2011) 0.87
Elimination of contact factor activation improves measurement of platelet-dependent thrombin generation by calibrated automated thrombography at low-concentration tissue factor. J Thromb Haemost (2006) 0.86
Response assessment in lymphoma. Clin Radiol (2007) 0.86
An internalized amino-terminal signal sequence retains full activity in vivo but not in vitro. J Biol Chem (1987) 0.85
High-dose carmustine, etoposide and melphalan ('BEM') with autologous stem cell transplantation: a dose-toxicity study. Bone Marrow Transplant (1996) 0.84
Travellers' thrombosis and economy class syndrome: incidence, aetiology and prevention. Clin Lab Haematol (2003) 0.84
CD28 and T cell co-stimulation. Rev Immunogenet (2000) 0.83
The treatment of chronic idiopathic thrombocytopenia with anti-D (Rho) immunoglobulin: its effectiveness, safety and mechanism of action. Clin Lab Haematol (1988) 0.82
Thrombocytopenia following liver transplantation is associated with platelet consumption and thrombin generation. Br J Haematol (1997) 0.82
Relative risk of pulmonary embolism and deep vein thrombosis in association with the factor V Leiden mutation in a United Kingdom population. Thromb Haemost (1997) 0.82
Pseudoaneurysm as a complication of arthroscopy: a case report. J Oral Maxillofac Surg (1991) 0.82
The role of individual Fc gamma receptors in aggregated IgG-stimulated protein tyrosine phosphorylation in the human neutrophil. Biochem Biophys Res Commun (1994) 0.81
Phenotypic characterization and analysis of allogeneic T cell responses in ZAP-70 dominant negative transgenic mice. Clin Exp Immunol (1997) 0.81
The risk of venous thrombosis associated with a high endogenous thrombin potential in the absence and presence of activated protein C. J Thromb Haemost (2006) 0.81
Prevention of infection by ciprofloxacin in neutropenia. J Antimicrob Chemother (1990) 0.81
Education and imaging. Hepatobiliary and pancreatic: peliosis hepatis. J Gastroenterol Hepatol (2011) 0.80
Haemoglobin Dhofar is linked to the codon 29 C-->T (IVS-1 nt-3) splice mutation which causes beta+ thalassaemia. Br J Haematol (1995) 0.80
Development of autoantibodies and factor VIII inhibitor in an HIV-infected haemophiliac following treatment with combination anti-retroviral therapy. Br J Haematol (1998) 0.80
Central venous thrombosis due to bolus injections of antileukaemic chemotherapy. Br J Haematol (1986) 0.79
Serum thrombopoietin levels following orthotopic liver transplantation. Thromb Haemost (1997) 0.79
CAMPATH-1 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpura. Br J Haematol (1993) 0.79
Expression of the CD2AP adaptor molecule in normal, reactive and neoplastic human tissue. Pathologica (2012) 0.79
Venous thromboembolism in oesophago-gastric carcinoma: incidence of symptomatic and asymptomatic events following chemotherapy and surgery. Eur J Surg Oncol (2011) 0.79
Imaging acute pancreatitis. Br J Radiol (2010) 0.79
Molecular genetic analysis of haematological malignancies II: Mature lymphoid neoplasms. Int J Lab Hematol (2007) 0.78
Assessment and management of immune thrombocytopenia in pregnancy and in neonates. Arch Dis Child Fetal Neonatal Ed (1995) 0.78
Acceptability of virtual unenhanced CT of the aorta as a replacement for the conventional unenhanced phase. Clin Radiol (2011) 0.78
Cleavage of rhamnose from ristocetin A removes its ability to induce platelet aggregation. Blood Coagul Fibrinolysis (1998) 0.78
Atherogenic lipoproteins support assembly of the prothrombinase complex and thrombin generation: modulation by oxidation and vitamin E. Blood (1998) 0.78
Solvent/detergent fresh frozen plasma as primary treatment of acute thrombotic thrombocytopenic purpura. Clin Lab Haematol (1999) 0.78
Is there a true difference in recurrence rate of deep venous thrombosis between men and women? J Thromb Haemost (2005) 0.77
Gentamicin and low dose piperacillin in febrile neutropenic patients. J Antimicrob Chemother (1989) 0.77
Donor factor V Leiden mutation and vascular thrombosis following liver transplantation. Liver Transpl Surg (1998) 0.77
A randomized trial of solvent/detergent and standard fresh frozen plasma in the treatment of the coagulopathy seen during Orthotopic Liver Transplantation. Vox Sang (1998) 0.77
Predictive value of von Willebrand factor to ristocetin cofactor ratio and thrombin-antithrombin complex levels for hepatic vessel thrombosis and graft rejection after liver transplantation. Transplantation (1994) 0.76